Tag: Diffuse Large B-Cell Lymphoma
Polatuzumab offers new hope for DLBCL patients on World Lymphoma Day
The first FDA-approved DLBCL treatment in nearly 20 years, Polatuzumab shows results in reducing relapse and disease progression